The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms

Basit Öğe Kaydı
dc.authoridGUNDUZ, Ozgur/0000-0002-2470-3021
dc.authoridUlugol, Ahmet/0000-0003-4643-1124
dc.contributor.authorGunduz, Ozgur
dc.contributor.authorYurtgezen, Zekiye Gulfem
dc.contributor.authorTopuz, Ruhan Deniz
dc.contributor.authorSapmaz-Metin, Melike
dc.contributor.authorKaya, Oktay
dc.contributor.authorOrhan, Abdullah Erkan
dc.contributor.authorUlugol, Ahmet
dc.date.accessioned2025-01-27T21:01:37Z
dc.date.available2025-01-27T21:01:37Z
dc.date.issued2023
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBackground and objectives: Neuropathic pain is defined as pain caused by damage to the nerve as a result of a lesion or disease. It has been shown that ischemic preconditioning exerts a protective role in various tissue injuries; however, the effect of transplantation of remote ischemic preconditioning serum (RIPCs) on neuropathic pain symptoms has not been studied. The aim of this project is to investigate the effect of RIPCs transfusion by different routes of administration on neuropathic pain symptoms. Our secondary aim was to demonstrate the role of Schwann cells in the regeneration of sciatic nerve injury and to evaluate the change in the number of glial cells in the spinal cord dorsal horn.Methods: The sciatic nerve partial ligation method was used to induce neuropathic pain. Changes in neuropathic pain symptoms were assessed by measuring thermal hyperalgesia and mechanical allodynia. To determine the possible therapeutic site, alterations in the number of spinal cord lumbar posterior horn microglia and astrocytes were evaluated by ionized calcium-binding adapter molecule 1 (iba1) and glial fibrillary acidic protein (GFAP) immunostaining. Myelin basic protein immunohistochemistry was also used to assess Schwann cell immunoreactivity in the sciatic nerve.Results: In rats that underwent partial sciatic nerve ligation, neuropathic pain symptoms developed on average on day 12 and persisted up to day 21 (p < 0.0001). RIPCs administered intravenously for five days reduced thermal hyperalgesia more than intraperitoneal and subcutaneous administration (p < 0.05). Both central glial cells appear to play a role in the effect of RIPCs. RIPCs treatment increases Schwann cell remyelination.Conclusions: Our results showed that intravenously administered RIPCs remarkably improved the neuropathic pain symptoms, thermal hyperalgesia and mechanical allodynia. Further studies are needed to evaluate the role of RIPCs transfusion on glial cells.
dc.description.sponsorshipTrakya University Research Council [TUBAP-2020/111]
dc.description.sponsorshipFunding his work was supported by a grant from Trakya University Research Council (TUBAP-2020/111) .
dc.identifier.doi10.1016/j.heliyon.2023.e20954
dc.identifier.issn2405-8440
dc.identifier.issue10
dc.identifier.pmid37867836
dc.identifier.scopus2-s2.0-85173696469
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.heliyon.2023.e20954
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27125
dc.identifier.volume9
dc.identifier.wosWOS:001114647100001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherCell Press
dc.relation.ispartofHeliyon
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectNeuropathic pain
dc.subjectRemote ischemic preconditioning
dc.subjectHyperalgesia
dc.subjectAllodynia
dc.subjectGlial cells
dc.titleThe therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu